Katarina Vasiljevic

Oncology
1000 Fivepoint Ste A
Irvine, CA 92618

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Pemigatinib in the Treatment of Metastatic, Inflammatory Triple-Negative Breast Cancer With FGFR2 Rearrangement: A Case Report and Review of the Literature.

Pemigatinib in the Treatment of Metastatic, Inflammatory Triple-Negative Breast Cancer With FGFR2 Rearrangement: A Case Report and Review of the Literature.

Journal: JCO precision oncology
Published: August 12, 2026
Showing 1-1 of 1

Last Updated: 09/26/2026